Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
29-Oct-26
$150m
$150mEST
n/a
On October 29, 2026, the Company announced that its Board of Directors had approved an additional $150 million increase to the existing authorization for the Company’s stock repurchase program.10-Q filed 29-Oct-26
30-Jul-26
$150m
$75m
n/a
On July 30, 2026, the Company announced that its Board of Directors had approved an additional $150 million increase to the existing authorization for the Company’s stock repurchase program, which has no fixed expiration date, for a total authorization of $550 million.10-Q filed 29-Oct-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)